Clinical Trial Supplies Companies

The clinical trial supplies market is projected to reach USD 8.95 billion by 2031, up from USD 5.60 billion in 2026, at a CAGR of 9.8% from 2026 to 2031. Rising clinical trial volumes, expanding pharmaceutical and biotechnology R&D, and wider use of decentralized and adaptive study designs are driving growth. Demand is also increasing for temperature-controlled logistics, direct-to-patient delivery, real-time inventory visibility, and compliant supply models for biologics and advanced therapies.

The global clinical trial supplies market is competitive, with leading participants including Almac Group (UK), Novo Holdings A/S (Catalent, Inc.) (Denmark), Marken (US), PCI Pharma Services (US), and Thermo Fisher Scientific (US). Providers compete through integrated sourcing, packaging and labeling, storage, distribution, returns, and destruction capabilities. Recent investment has focused on depot networks, cold-chain capacity, digital forecasting and tracking, direct-to-patient models, and geographic expansion to support increasingly complex multicountry trials.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific (US)

Thermo Fisher Scientific provides end-to-end clinical trial supply services for small molecules, biologics, and advanced therapies. Its capabilities include demand planning, comparator and ancillary sourcing, primary and secondary packaging, labeling, cGMP storage, cold-chain management, and global distribution. Through its network of purpose-built clinical supply facilities, the company supports studies across all development phases, helping sponsors maintain product integrity, regulatory compliance, inventory control, and timely delivery to clinical sites and patients worldwide.

Novo Holdings A/S (Catalent, Inc.) (Denmark)

Catalent, an operating company owned by Novo Holdings A/S, provides end-to-end clinical supply services from first-in-human through late-stage trials. Its portfolio combines planning, packaging and labeling, logistics, storage, and distribution, supported by a global network. The company also offers demand-led supply models, direct-to-patient solutions, and the OneHub portal for near-real-time inventory, expiry, and shipment visibility, helping sponsors manage complex small-molecule, biologic, cell therapy, and gene therapy programs.

Eurofins Scientific (Luxembourg)

Eurofins Scientific supports clinical trials through dedicated supply services for Investigational Medicinal Products and Advanced Therapy Medicinal Products. Its capabilities include primary and secondary packaging, labeling, Qualified Person services, and global distribution. The offering helps sponsors prepare, release, and deliver trial materials in accordance with applicable quality requirements while coordinating international supply activities for conventional medicines and advanced therapies.

Market Ranking

The clinical trial supplies market includes global full-service providers and a broad base of regional and specialist firms. Global providers hold strong positions because they combine GMP packaging, temperature-controlled storage, depot and courier networks, regulatory support, and digital inventory visibility. Scale matters most for multicountry Phase II and Phase III studies, decentralized trials, and biologic or cell and gene therapy programs that require rapid resupply, chain-of-custody controls, and specialized temperature ranges.

Thermo Fisher Scientific (US) provides end-to-end clinical supply optimization, comparator sourcing, packaging, labeling, storage, cold-chain management, and global distribution through its Patheon pharma services network. Novo Holdings A/S (Denmark), through its portfolio company Catalent (US), supports local and global studies with integrated packaging, labeling, storage, distribution, returns management, and digital supply-chain visibility. Eurofins Scientific (Luxembourg) provides primary and secondary packaging, labeling, Qualified Person services, and global distribution for Investigational Medicinal Products and Advanced Therapy Medicinal Products.

Almac Group (UK) offers comparator sourcing, blinding, primary and secondary packaging, Qualified Person services, temperature management, storage, distribution, and IRT-linked supply-chain support. Marken (US), part of UPS Healthcare, differentiates itself through healthcare logistics, cold-chain orchestration, direct-to-patient services, advanced-therapy transport, and sample management. PCI Pharma Services (US) combines clinical packaging, labeling, storage, distribution, returns, and temperature-controlled logistics with broader development and manufacturing capabilities. Other recognized participants include Sharp, Eurofins, Parexel, ICON, IQVIA, BioCair, Piramal Pharma, and Lonza.

The remainder of the market consists of regional logistics providers, specialist packaging companies, comparator-sourcing firms, depot operators, and ancillary-supply partners. These companies compete through local regulatory knowledge, flexible capacity, therapeutic-area expertise, and access to emerging trial locations. Opportunities are strongest where sponsors need just-in-time labeling, direct-to-patient delivery, country-specific sourcing, lower-volume specialist packaging, or temperature-controlled distribution without committing to a single global provider.

Related Reports:

Clinical Trial Supplies Market by Service [Manufacturing, Packaging (Primary, Secondary), Logistics], Phases, Type (Small Molecules, Biologics, Vaccine), Therapeutic Areas (Oncology, Neurology, Ophthalmology, Dermatology), Region - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]